# Safety of Itacitinib in Combination With Corticosteroids for Treatment of Steroid-Naive Acute Graft-Versus-Host Disease in Japanese Subjects

> **NCT03497273** · PHASE1 · COMPLETED · sponsor: **Incyte Corporation** · enrollment: 14 (actual)

## Conditions studied

- Acute Graft-versus-host Disease

## Interventions

- **DRUG:** Itacitinib
- **DRUG:** Corticosteroid

## Key facts

- **NCT ID:** NCT03497273
- **Lead sponsor:** Incyte Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-20
- **Primary completion:** 2019-11-30
- **Final completion:** 2020-02-17
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2020-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03497273

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03497273, "Safety of Itacitinib in Combination With Corticosteroids for Treatment of Steroid-Naive Acute Graft-Versus-Host Disease in Japanese Subjects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03497273. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*